Anti-CD200 Reference Antibody (samalizumab)
- Product Code: 139876
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in research and development of therapies targeting immune regulation, particularly in oncology and chronic inflammatory diseases. Binds to CD200, a cell surface glycoprotein that modulates immune responses, helping to disrupt immunosuppressive signals in the tumor microenvironment. Investigated for potential in treating hematologic malignancies such as chronic lymphocytic leukemia (CLL) and multiple myeloma by enhancing immune system recognition and attack of cancer cells. Also serves as a reference standard in immunoassays and antibody development workflows.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CD200 Reference Antibody (samalizumab)
Used in research and development of therapies targeting immune regulation, particularly in oncology and chronic inflammatory diseases. Binds to CD200, a cell surface glycoprotein that modulates immune responses, helping to disrupt immunosuppressive signals in the tumor microenvironment. Investigated for potential in treating hematologic malignancies such as chronic lymphocytic leukemia (CLL) and multiple myeloma by enhancing immune system recognition and attack of cancer cells. Also serves as a reference standard in immunoassays and antibody development workflows.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :